Remedi KRX:387690KOSDAQ
레메디 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days1
Articles tracked11since Sep 11
In Q2 2026, Remedi reported revenue of ₩6.2bn, up 61.2% year on year, and operating profit of ₩2.8bn. Remedi (레메디) appeared in 0 Korean news articles and 1 DART filing over the past seven days. Coverage peaked on Oct 21 with 3 articles.
Filing signals Op. margin 20%+ Screener
Remedi quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩6.2bn | +61.2% | ₩2.8bn margin 45.8% | ₩1.9bn |
| Q2 2025 | ₩3.8bn | – | ₩542m margin 14.1% | ₩336m |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Remedi top stories 2 weeks, by number of outlets
- 1
- 2
- 3